AU2020317617A1 - Detection of genomic sequences using combinations of probes, probe molecules and arrays comprising the probes for the specific detection of organisms - Google Patents
Detection of genomic sequences using combinations of probes, probe molecules and arrays comprising the probes for the specific detection of organisms Download PDFInfo
- Publication number
- AU2020317617A1 AU2020317617A1 AU2020317617A AU2020317617A AU2020317617A1 AU 2020317617 A1 AU2020317617 A1 AU 2020317617A1 AU 2020317617 A AU2020317617 A AU 2020317617A AU 2020317617 A AU2020317617 A AU 2020317617A AU 2020317617 A1 AU2020317617 A1 AU 2020317617A1
- Authority
- AU
- Australia
- Prior art keywords
- probe
- genome
- virtual
- seq
- amplicon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 title claims abstract description 617
- 238000003491 array Methods 0.000 title abstract description 12
- 238000001514 detection method Methods 0.000 title description 19
- 238000011895 specific detection Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 184
- 241000894006 Bacteria Species 0.000 claims abstract description 33
- 108091093088 Amplicon Proteins 0.000 claims description 303
- 125000003729 nucleotide group Chemical group 0.000 claims description 198
- 239000002773 nucleotide Substances 0.000 claims description 197
- 150000007523 nucleic acids Chemical class 0.000 claims description 123
- 108020004707 nucleic acids Proteins 0.000 claims description 121
- 102000039446 nucleic acids Human genes 0.000 claims description 121
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 119
- 239000002751 oligonucleotide probe Substances 0.000 claims description 119
- 238000012408 PCR amplification Methods 0.000 claims description 99
- 238000006243 chemical reaction Methods 0.000 claims description 96
- 244000005700 microbiome Species 0.000 claims description 67
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 40
- 238000012360 testing method Methods 0.000 claims description 40
- 241001134658 Streptococcus mitis Species 0.000 claims description 39
- 238000009396 hybridization Methods 0.000 claims description 37
- 230000000295 complement effect Effects 0.000 claims description 28
- 108010065152 Coagulase Proteins 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 241000194008 Streptococcus anginosus Species 0.000 claims description 19
- 241000194026 Streptococcus gordonii Species 0.000 claims description 19
- 241000191940 Staphylococcus Species 0.000 claims description 17
- 108700022487 rRNA Genes Proteins 0.000 claims description 17
- 108091023242 Internal transcribed spacer Proteins 0.000 claims description 13
- 108091034117 Oligonucleotide Proteins 0.000 claims description 13
- 230000003287 optical effect Effects 0.000 claims description 13
- 241001147693 Staphylococcus sp. Species 0.000 claims description 12
- 230000000977 initiatory effect Effects 0.000 claims description 12
- 241000193998 Streptococcus pneumoniae Species 0.000 claims description 10
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 10
- 238000004458 analytical method Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 6
- 230000027455 binding Effects 0.000 abstract description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 134
- 239000000047 product Substances 0.000 description 89
- 241000894007 species Species 0.000 description 68
- 108020004414 DNA Proteins 0.000 description 51
- 230000003321 amplification Effects 0.000 description 37
- 238000003199 nucleic acid amplification method Methods 0.000 description 37
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 28
- 229940104230 thymidine Drugs 0.000 description 24
- 239000012530 fluid Substances 0.000 description 21
- 238000003753 real-time PCR Methods 0.000 description 21
- 238000007846 asymmetric PCR Methods 0.000 description 19
- 108091028043 Nucleic acid sequence Proteins 0.000 description 18
- 239000012472 biological sample Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 15
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- 239000007850 fluorescent dye Substances 0.000 description 11
- 230000002441 reversible effect Effects 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 238000000137 annealing Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000004544 DNA amplification Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000012807 PCR reagent Substances 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000007613 environmental effect Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000002372 labelling Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 210000003802 sputum Anatomy 0.000 description 6
- 208000024794 sputum Diseases 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 241000881810 Enterobacter asburiae Species 0.000 description 5
- 241000588697 Enterobacter cloacae Species 0.000 description 5
- 241000043309 Enterobacter hormaechei Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 238000010009 beating Methods 0.000 description 5
- 230000009260 cross reactivity Effects 0.000 description 5
- 238000002493 microarray Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 239000003330 peritoneal dialysis fluid Substances 0.000 description 5
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
- 241000588921 Enterobacteriaceae Species 0.000 description 4
- 241000588915 Klebsiella aerogenes Species 0.000 description 4
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 4
- 241000194025 Streptococcus oralis Species 0.000 description 4
- 239000000370 acceptor Substances 0.000 description 4
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 229940092559 enterobacter aerogenes Drugs 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229960003085 meticillin Drugs 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 3
- 241000588626 Acinetobacter baumannii Species 0.000 description 3
- 241000194032 Enterococcus faecalis Species 0.000 description 3
- 241000194031 Enterococcus faecium Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241000588749 Klebsiella oxytoca Species 0.000 description 3
- 241000588747 Klebsiella pneumoniae Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000205160 Pyrococcus Species 0.000 description 3
- 241000295644 Staphylococcaceae Species 0.000 description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 description 3
- 241000191982 Staphylococcus hyicus Species 0.000 description 3
- 241001134656 Staphylococcus lugdunensis Species 0.000 description 3
- 241000193985 Streptococcus agalactiae Species 0.000 description 3
- 241000193996 Streptococcus pyogenes Species 0.000 description 3
- 241000194024 Streptococcus salivarius Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 108091036078 conserved sequence Proteins 0.000 description 3
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 3
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 3
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000007403 mPCR Methods 0.000 description 3
- 230000006855 networking Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 3
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LLTDOAPVRPZLCM-UHFFFAOYSA-O 4-(7,8,8,16,16,17-hexamethyl-4,20-disulfo-2-oxa-18-aza-6-azoniapentacyclo[11.7.0.03,11.05,9.015,19]icosa-1(20),3,5,9,11,13,15(19)-heptaen-12-yl)benzoic acid Chemical compound CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)[NH+]=4)(C)C)=CC3=3)S(O)(=O)=O)S(O)(=O)=O)=C1C=C2C=3C1=CC=C(C(O)=O)C=C1 LLTDOAPVRPZLCM-UHFFFAOYSA-O 0.000 description 2
- 241000588625 Acinetobacter sp. Species 0.000 description 2
- 241001147825 Actinomyces sp. Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000588832 Bordetella pertussis Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 206010050337 Cerumen impaction Diseases 0.000 description 2
- 201000005019 Chlamydia pneumonia Diseases 0.000 description 2
- 241000588923 Citrobacter Species 0.000 description 2
- 241000158508 Corynebacterium amycolatum Species 0.000 description 2
- 229930183912 Cytidylic acid Natural products 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- 241001078637 Enterobacter cloacae complex Species 0.000 description 2
- 241000305071 Enterobacterales Species 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 241000606790 Haemophilus Species 0.000 description 2
- 241000606768 Haemophilus influenzae Species 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 241000712431 Influenza A virus Species 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 241000589248 Legionella Species 0.000 description 2
- 241001424413 Lucia Species 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- 241000191938 Micrococcus luteus Species 0.000 description 2
- 241000588655 Moraxella catarrhalis Species 0.000 description 2
- 241000186367 Mycobacterium avium Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
- PKFBJSDMCRJYDC-GEZSXCAASA-N N-acetyl-s-geranylgeranyl-l-cysteine Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CSC[C@@H](C(O)=O)NC(C)=O PKFBJSDMCRJYDC-GEZSXCAASA-N 0.000 description 2
- 241000588650 Neisseria meningitidis Species 0.000 description 2
- 241000187681 Nocardia sp. Species 0.000 description 2
- 208000026681 Paratuberculosis Diseases 0.000 description 2
- 241000142787 Pneumocystis jirovecii Species 0.000 description 2
- 241000588770 Proteus mirabilis Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000607149 Salmonella sp. Species 0.000 description 2
- 241000607715 Serratia marcescens Species 0.000 description 2
- 241000122971 Stenotrophomonas Species 0.000 description 2
- 241000911872 Streptococcus anginosus group Species 0.000 description 2
- 241000194048 Streptococcus equi Species 0.000 description 2
- 241000194049 Streptococcus equinus Species 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 241000205188 Thermococcus Species 0.000 description 2
- 241000589634 Xanthomonas Species 0.000 description 2
- 210000004381 amniotic fluid Anatomy 0.000 description 2
- 244000037640 animal pathogen Species 0.000 description 2
- 210000003567 ascitic fluid Anatomy 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000002939 cerumen Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 239000003673 groundwater Substances 0.000 description 2
- 229940047650 haemophilus influenzae Drugs 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 244000052637 human pathogen Species 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000005055 memory storage Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 208000030773 pneumonia caused by chlamydia Diseases 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 238000011897 real-time detection Methods 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 229940030998 streptococcus agalactiae Drugs 0.000 description 2
- 239000002352 surface water Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
- SJQRQOKXQKVJGJ-UHFFFAOYSA-N 5-(2-aminoethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1S(O)(=O)=O SJQRQOKXQKVJGJ-UHFFFAOYSA-N 0.000 description 1
- NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 241001148231 Acinetobacter haemolyticus Species 0.000 description 1
- 241000122230 Acinetobacter junii Species 0.000 description 1
- 241001556024 Acinetobacter ursingii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000701897 Bacillus virus B103 Species 0.000 description 1
- 240000001817 Cereus hexagonus Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- ZWIADYZPOWUWEW-UHFFFAOYSA-N Cytidine 5'-diphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-UHFFFAOYSA-N 0.000 description 1
- PCDQPRRSZKQHHS-UHFFFAOYSA-N Cytidine 5'-triphosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical compound C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014666 Endocarditis bacterial Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000567769 Isurus oxyrinchus Species 0.000 description 1
- 241000579722 Kocuria Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000211181 Manta Species 0.000 description 1
- 241000589496 Meiothermus ruber Species 0.000 description 1
- 241001302042 Methanothermobacter thermautotrophicus Species 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589755 Pseudomonas mendocina Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 241000205156 Pyrococcus furiosus Species 0.000 description 1
- 241000531138 Pyrolobus fumarii Species 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 241000191980 Staphylococcus intermedius Species 0.000 description 1
- 241001291896 Streptococcus constellatus Species 0.000 description 1
- 241001288016 Streptococcus gallolyticus Species 0.000 description 1
- 241000194047 Streptococcus hyointestinalis Species 0.000 description 1
- 241001473878 Streptococcus infantarius Species 0.000 description 1
- 241000193991 Streptococcus parasanguinis Species 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000205098 Sulfolobus acidocaldarius Species 0.000 description 1
- 241000205091 Sulfolobus solfataricus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000204673 Thermoplasma acidophilum Species 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 241000589498 Thermus filiformis Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 241000186561 [Clostridium] clostridioforme Species 0.000 description 1
- 241000193462 [Clostridium] innocuum Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 208000009361 bacterial endocarditis Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000003103 bodily secretion Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZWIADYZPOWUWEW-ZAKLUEHWSA-N cytidine-5'-diphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO[P@](O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-ZAKLUEHWSA-N 0.000 description 1
- PCDQPRRSZKQHHS-ZAKLUEHWSA-N cytidine-5'-triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-ZAKLUEHWSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000003366 endpoint assay Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 244000005702 human microbiome Species 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 201000007119 infective endocarditis Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000001006 meconium Anatomy 0.000 description 1
- NFGXHKASABOEEW-LDRANXPESA-N methoprene Chemical compound COC(C)(C)CCCC(C)C\C=C\C(\C)=C\C(=O)OC(C)C NFGXHKASABOEEW-LDRANXPESA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/10—Detection mode being characterised by the assay principle
- C12Q2565/102—Multiple non-interacting labels
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/501—Detection characterised by immobilisation to a surface being an array of oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962876413P | 2019-07-19 | 2019-07-19 | |
US62/876,413 | 2019-07-19 | ||
US202063004664P | 2020-04-03 | 2020-04-03 | |
US63/004,664 | 2020-04-03 | ||
PCT/EP2020/070308 WO2021013736A1 (en) | 2019-07-19 | 2020-07-17 | Detection of genomic sequences using combinations of probes, probe molecules and arrays comprising the probes for the specific detection of organisms |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2020317617A1 true AU2020317617A1 (en) | 2022-03-03 |
Family
ID=71670264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020317617A Pending AU2020317617A1 (en) | 2019-07-19 | 2020-07-17 | Detection of genomic sequences using combinations of probes, probe molecules and arrays comprising the probes for the specific detection of organisms |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220267833A1 (zh) |
EP (1) | EP3999658A1 (zh) |
JP (1) | JP2022540716A (zh) |
KR (1) | KR20220035482A (zh) |
CN (1) | CN114269944A (zh) |
AU (1) | AU2020317617A1 (zh) |
BR (1) | BR112021026672A2 (zh) |
CA (1) | CA3147364A1 (zh) |
IL (1) | IL289760A (zh) |
MX (1) | MX2022000628A (zh) |
TW (1) | TW202117021A (zh) |
WO (1) | WO2021013736A1 (zh) |
ZA (1) | ZA202200284B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11562057B2 (en) | 2020-02-05 | 2023-01-24 | Quantum Digital Solutions Corporation | Ecosystem security platforms for enabling data exchange between members of a digital ecosystem using digital genomic data sets |
WO2022169969A1 (en) * | 2021-02-04 | 2022-08-11 | Quantum Digital Solutions Corporation | Cyphergenics-based ecosystem security platforms |
JP2024507719A (ja) | 2021-02-04 | 2024-02-21 | クアンタム デジタル ソリューションズ コーポレーション | サイファージェニクスベースのエコシステムセキュリティプラットフォーム |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066584A (en) | 1988-09-23 | 1991-11-19 | Cetus Corporation | Methods for generating single stranded dna by the polymerase chain reaction |
US6638719B1 (en) * | 1999-07-14 | 2003-10-28 | Affymetrix, Inc. | Genotyping biallelic markers |
US20030134293A1 (en) * | 1999-11-16 | 2003-07-17 | Zhiping Liu | Method for rapid and accurate identification of microorganisms |
US7205104B2 (en) * | 2000-03-24 | 2007-04-17 | Eppendorf Array Technologies Sa (Eat) | Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays |
CN1280422C (zh) | 2004-08-26 | 2006-10-18 | 北京博奥生物芯片有限责任公司 | 一种不对称pcr扩增方法及其应用 |
EP2176281A4 (en) * | 2007-07-11 | 2010-09-15 | Univ Laval | NUCLEIC ACID SEQUENCES AND COMBINATION THEREOF FOR SENSITIVE AMPLIFICATION AND SENSITIVE DETECTION OF BACTERIAL AND MIRACLE SEPSISPATHOGENESE |
EP3181700A1 (en) | 2015-12-18 | 2017-06-21 | Safeguard Biosystems Holdings Ltd. | Three-dimensional polymer networks with channels situated therein |
US10036054B2 (en) | 2016-01-30 | 2018-07-31 | Safeguard Biosystems Holdings Ltd. | Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms |
EP3418741A1 (en) | 2017-06-19 | 2018-12-26 | Safeguard Biosystems Holdings Ltd. | Three-dimensional polymer networks and their use |
US10513730B2 (en) | 2017-11-22 | 2019-12-24 | Safeguard Biosystems Holdings Ltd. | Asymmetric PCR methods, primers and kits |
-
2020
- 2020-07-17 BR BR112021026672A patent/BR112021026672A2/pt unknown
- 2020-07-17 WO PCT/EP2020/070308 patent/WO2021013736A1/en unknown
- 2020-07-17 KR KR1020227005634A patent/KR20220035482A/ko unknown
- 2020-07-17 EP EP20742724.6A patent/EP3999658A1/en active Pending
- 2020-07-17 TW TW109124256A patent/TW202117021A/zh unknown
- 2020-07-17 AU AU2020317617A patent/AU2020317617A1/en active Pending
- 2020-07-17 US US17/628,038 patent/US20220267833A1/en active Pending
- 2020-07-17 CN CN202080059564.6A patent/CN114269944A/zh active Pending
- 2020-07-17 JP JP2022503578A patent/JP2022540716A/ja active Pending
- 2020-07-17 CA CA3147364A patent/CA3147364A1/en active Pending
- 2020-07-17 MX MX2022000628A patent/MX2022000628A/es unknown
-
2022
- 2022-01-05 ZA ZA2022/00284A patent/ZA202200284B/en unknown
- 2022-01-11 IL IL289760A patent/IL289760A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112021026672A2 (pt) | 2022-02-15 |
CN114269944A (zh) | 2022-04-01 |
WO2021013736A1 (en) | 2021-01-28 |
JP2022540716A (ja) | 2022-09-16 |
MX2022000628A (es) | 2022-03-11 |
IL289760A (en) | 2022-03-01 |
ZA202200284B (en) | 2022-09-28 |
TW202117021A (zh) | 2021-05-01 |
US20220267833A1 (en) | 2022-08-25 |
KR20220035482A (ko) | 2022-03-22 |
CA3147364A1 (en) | 2021-01-28 |
EP3999658A1 (en) | 2022-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220267833A1 (en) | Detection of genomic sequences using combinations of probes, probe molecules and arrays comprising the probes for the specific detection of organisms | |
JP2013531983A (ja) | 多重生物検出のための核酸ならびにその使用および製造方法 | |
BRPI0517131B1 (pt) | Métodos para simplificar ácidos nucléicos microbiais por modificação química de citosinas | |
WO2014106076A2 (en) | Universal sanger sequencing from next-gen sequencing amplicons | |
EP2344673B1 (en) | Diagnostic test for streptococcus equi | |
WO2013173774A2 (en) | Molecular inversion probes | |
US20080228406A1 (en) | System and method for fungal identification | |
JP5916740B2 (ja) | 核酸標的の定量的多重同定 | |
US20210017582A1 (en) | Detection of genomic sequences and probe molecules therefor | |
CN113136443B (zh) | 一种快速鉴定蜡样芽胞杆菌和苏云金芽胞杆菌的核酸检测方法 | |
WO2022157248A1 (en) | Improved detection of genomic sequences and probe molecules therefor | |
WO2022157672A1 (en) | Improved detection of genomic sequences and probe molecules therefor | |
CN101092645B (zh) | 诊断性传染病致病原的新颖方法 | |
US8304184B2 (en) | Genotyping using multiple variant-specific primer pools | |
KR20100012319A (ko) | 패혈증유발 미생물의 분류 및 동정 방법 | |
Nazir | Polymerase Chain Reaction | |
WO2024030342A1 (en) | Methods and compositions for nucleic acid analysis | |
EP4058605A1 (en) | Method of determining the presence of a hyper-virulent clostridioides difficile strain of the b1/nap1/027 group in a sample | |
JP2023511909A (ja) | 細菌定量化方法 | |
CN116356049A (zh) | 一种检测艰难梭状芽孢杆菌的试剂盒 | |
CN116356075A (zh) | 一种用于检测的引物探针、引物探针组及其应用 | |
BR102014008162A2 (pt) | método de identificação de espécies bacterianas e kit para o diagnóstico de bactérias |